Sutro Biopharma Grabs $36.5 Million in Venture Deal to Make ‘Biobetters’

The buzzphrase “biobetter” is starting to catch on, and South San Francisco-based Sutro Biopharma is the latest to cash in on the trend, as one of the companies hoping to develop drugs with nifty new properties that were never seriously considered before.
Xconomy